NEW YORK ( TheStreet) -- Biosante Pharmaceuticals (Nasdaq: BPAX) is trading at unusually high volume Thursday with 10.4 million shares changing hands. It is currently at four times its average daily volume and trading down 12 cents (-3.9%) at $2.98 as of 3:41 p.m. ET.

Biosante has a market cap of $305.1 million and is part of the health care sector and drugs industry. Shares are up 89% year to date as of the close of trading on Wednesday.

BioSante Pharmaceuticals, Inc., a specialty pharmaceutical company, develops products for female sexual health and oncology.

TheStreet Ratings rates Biosante as a sell. The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income and weak operating cash flow. You can view the full Biosante Ratings Report.

See all heavy volume stocks in our stocks moving on unusual volume list or get investment ideas from our investment research center.

Interested in other stocks that are falling on unusually high volume? Get free SMS text alerts sent to you when the action happens by texting HVDOWN to 95370 or select from multiple alert options.
null

If you liked this article you might like

The Worst Biotech CEO of 2012 Is...

Your Vote Counts: Who Is the Worst Biotech CEO of 2012?

The Next Big Thing in Biotech: Worst CEO Candidates

4 Biotech Stocks Under $10 Soaring Higher

5 Biotech Stocks Under $5 Blasting Off